NasdaqGM - Delayed Quote USD
Astria Therapeutics, Inc. (ATXS)
3.9000
-0.4700
(-10.76%)
At close: May 13 at 4:00:02 PM EDT
3.9000
0.00
(0.00%)
After hours: May 13 at 5:57:47 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 5 |
| Avg. Estimate | -0.47 | -0.49 | -1.93 | -1.97 |
| Low Estimate | -0.5 | -0.51 | -2.02 | -2.36 |
| High Estimate | -0.45 | -0.46 | -1.79 | -1.65 |
| Year Ago EPS | -- | -- | -1.68 | -1.93 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 8 | 8 |
| Avg. Estimate | -- | -- | -- | 625k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 5M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.4 | -0.42 | -0.45 | -0.48 |
| EPS Actual | -0.43 | -0.42 | -0.44 | -0.58 |
| Difference | -0.03 | 0 | 0.01 | -0.1 |
| Surprise % | -8.18% | 0.47% | 2.58% | -21.47% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.47 | -0.49 | -1.93 | -1.97 |
| 7 Days Ago | -0.47 | -0.49 | -1.92 | -1.91 |
| 30 Days Ago | -0.47 | -0.49 | -1.92 | -1.91 |
| 60 Days Ago | 0 | 0 | -1.85 | -1.65 |
| 90 Days Ago | 0 | 0 | -1.85 | -1.65 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ATXS | -- | -- | -14.88% | -1.97% |
| S&P 500 | 13.17% | 3.05% | 8.05% | 13.75% |
Upgrades & Downgrades
| Initiated | Cantor Fitzgerald: Overweight | 4/29/2025 |
| Maintains | Wedbush: Outperform to Outperform | 3/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/3/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
| Initiated | JMP Securities: Market Outperform | 1/31/2025 |
Related Tickers
DNTH Dianthus Therapeutics, Inc.
18.84
-6.18%
ANTX AN2 Therapeutics, Inc.
1.1800
-0.84%
PHVS Pharvaris N.V.
16.11
-4.16%
HLVX HilleVax, Inc.
1.9200
+1.59%
ORKA Oruka Therapeutics, Inc.
9.62
-1.33%
KZR Kezar Life Sciences, Inc.
4.2000
-0.71%
RPTX Repare Therapeutics Inc.
1.4300
+5.15%
TBPH Theravance Biopharma, Inc.
8.91
+1.25%
IPSC Century Therapeutics, Inc.
0.5260
+0.25%
DAWN Day One Biopharmaceuticals, Inc.
6.33
-3.80%